Barclays’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,084
Closed -$3K 7594
2018
Q4
$3K Sell
25,084
-166,403
-87% -$109K ﹤0.01% 6676
2018
Q3
$326K Sell
191,487
-151,302
-44% -$271K ﹤0.01% 4614
2018
Q2
$596K Sell
342,789
-262,609
-43% -$454K ﹤0.01% 3784
2018
Q1
$1.11M Buy
605,398
+550,954
+1,012% +$1.16M ﹤0.01% 3082
2017
Q4
$121K Buy
54,444
+24,778
+84% +$61.6K ﹤0.01% 5096
2017
Q3
$86K Buy
29,666
+14,499
+96% +$49.5K ﹤0.01% 5029
2017
Q2
$68K Sell
15,167
-13,183
-47% -$54.4K ﹤0.01% 5168
2017
Q1
$132K Buy
28,350
+868
+3% +$5.03K ﹤0.01% 4681
2016
Q4
$167K Buy
27,482
+18,520
+207% +$96.8K ﹤0.01% 4366
2016
Q3
$49K Buy
+8,962
New +$42K ﹤0.01% 4994
2016
Q2
Sell
-14,213
Closed -$28K 6834
2016
Q1
$28K Sell
14,213
-201,229
-93% -$729K ﹤0.01% 5088
2015
Q4
$1.08M Buy
215,442
+37,853
+21% +$231K ﹤0.01% 2552
2015
Q3
$889K Buy
177,589
+73,982
+71% +$573K ﹤0.01% 2838
2015
Q2
$829K Sell
103,607
-8,410
-8% -$40.8K ﹤0.01% 3051
2015
Q1
$447K Buy
112,017
+101,472
+962% +$330K ﹤0.01% 3695
2014
Q4
$31K Buy
10,545
+1,010
+11% +$2.99K ﹤0.01% 6050
2014
Q3
$19K Sell
9,535
-10,446
-52% -$37.9K ﹤0.01% 6520
2014
Q2
$79K Buy
19,981
+6,302
+46% +$26.8K ﹤0.01% 5606
2014
Q1
$69K Buy
13,679
+5,615
+70% +$31.5K ﹤0.01% 5739
2013
Q4
$40K Buy
8,064
+3,041
+61% +$13.1K ﹤0.01% 6342
2013
Q3
$20K Sell
5,023
-6,548
-57% -$29.4K ﹤0.01% 6538
2013
Q2
$50K Buy
+11,571
New +$58.1K ﹤0.01% 6306

Other funds holding SGYP